2022 Outstanding Scientific Achievement Award - Anna L. Gloyn, DPhil

2022 Outstanding Scientific Achievement Award
Anna L. Gloyn, DPhil

Outstanding Scientific Achievement Award Lecture
"Mining the genome for gold: Drilling down on mechanisms for pancreatic islet cell dysfunction in diabetes"

Dr Anna Gloyn joined the faculty at Stanford University in February 2020 as Professor of Pediatrics & by Courtesy Genetics.   She completed her DPhil at the University of Oxford under the supervision of the late Professor Robert C. Turner, followed by post-doctoral training with Professors Andrew Hattersley & Sian Ellard (University of Exeter, UK) and Professor Franz Matschinsky (University of Pennsylvania, USA). Her DPhil and post-doctoral research were both focused on the role of genetic variation in the genes encoding the KATP channel initially in type 2 diabetes and subsequently in neonatal diabetes. 

In 2004 she returned to Oxford where she established an independent research group focused on understanding beta-cell function through the functional characterization of genetic variants causally implicated in monogenic diabetes.  For the past 10 years a major focus of her work has been on translating discoveries from genome-wide association studies into biological and clinical insights.  Her research combines genetic discovery and functional genomics with clinical phenotyping and disease modelling in human cell models to elucidate how changes in DNA sequence alter diabetes risk. 

Her work is highly collaborative, she plays roles in multiple international consortia including the Accelerated Medicines Partnership for Common Metabolic Disease (AMP-CMD) and the Human Islet Research Network (HIRN). 

Dr Gloyn is the recipient of the European Association for the Study of Diabetes (EASD) Rising Star (2005) and Minkowski (2014) awards, the Diabetes UK RD Lawrence (2009) and Dorothy Hodgkin (2019) Prize Lectures and the G.B. Morgagni Silver Medal (2014).

Please join us in celebrating Anna Gloyn, DPhil, for her transformative contributions to basic and translational diabetes research.